1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Indication Roadmap
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Drug Innovation / Key Development Trends
4. Key Success Factors
4.1. Pipeline Assessment
4.2. Disease Treatment Pathophysiology
4.3. Key Regulations
4.4. Disease Epidemiology
5. Global Market Demand (in Value or Size in US$ Mn) Analysis 2018-2022 and Forecast, 2023-2033
5.1. Historical Market Value (US$ Mn) Analysis, 2018-2022
5.2. Current and Future Market Value (US$ Mn) Projections, 2023-2033
5.2.1. Y-o-Y Growth Trend Analysis
5.2.2. Absolute $ Opportunity Analysis
6. Market Background
6.1. Macro-Economic Factors
6.1.1. Global GDP Growth Outlook
6.1.2. Global Healthcare Expenditure Outlook
6.2. Forecast Factors – Relevance & Impact
6.2.1. Expenditure on R&D by Pharmaceutical Companies
6.2.2. Cost of Drugs
6.2.3. Merger and Acquisitions
6.2.4. Collaborative Agreements
6.3. Value Chain
6.4. Market Dynamics
6.4.1. Drivers
6.4.2. Restraints
6.4.3. Opportunity Analysis
7. Global Market Analysis 2018-2022 and Forecast 2023-2033, by Drug Type
7.1. Introduction / Key Findings
7.2. Historical Market Size (US$ Mn) Analysis By Drug Type, 2018-2022
7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Drug Type, 2023-2033
7.3.1. Cholinesterase Inhibitors
7.3.2. Antipsychotic Drugs
7.3.3. Carbidopa-Levodopa
7.3.4. Antidepressants
7.3.5. Benzodiazepine
7.3.6. Modafinil
7.4. Market Attractiveness Analysis By Drug Type
8. Global Market Analysis 2018-2022 and Forecast 2023-2033, by Indication
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Indication, 2018-2022
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Indication, 2023-2033
8.3.1. Dementia with Lewy Bodies (DLB)
8.3.2. Parkinson’s Disease (PD)
8.4. Market Attractiveness Analysis By Indication
9. Global Market Analysis 2018-2022 and Forecast 2023-2033, by Distribution Channel
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2018-2022
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2023-2033
9.3.1. Hospital Pharmacies
9.3.2. Retail Pharmacies
9.3.3. Drug Stores
9.3.4. Online Pharmacies
9.4. Market Attractiveness Analysis By Distribution Channel
10. Global Market Analysis 2018-2022 and Forecast 2023-2033, by Region
10.1. Introduction
10.2. Historical Market Size (US$ Mn) Analysis By Region, 2018-2022
10.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2023-2033
10.3.1. North America
10.3.2. Latin America
10.3.3. Europe
10.3.4. Middle East and Africa (MEA)
10.3.5. East Asia
10.3.6. South Asia
10.3.7. Oceania
10.4. Market Attractiveness Analysis By Region
11. North America Market Analysis 2018-2022 and Forecast 2023-2033
11.1. Introduction
11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022
11.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2023-2033
11.3.1. By Country
11.3.1.1. U.S.
11.3.1.2. Canada
11.3.2. By Drug Type
11.3.3. By Indication
11.3.4. By Distribution Channel
11.4. Market Attractiveness Analysis
12. Latin America Market Analysis 2018-2022 and Forecast 2023-2033
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022
12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2023-2033
12.3.1. By Country
12.3.1.1. Brazil
12.3.1.2. Mexico
12.3.1.3. Argentina
12.3.1.4. Rest of Latin America
12.3.2. By Drug Type
12.3.3. By Indication
12.3.4. By Distribution Channel
12.4. Market Attractiveness Analysis
13. Europe Market Analysis 2018-2022 and Forecast 2023-2033
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022
13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2023-2033
13.3.1. By Country
13.3.1.1. U.K.
13.3.1.2. Germany
13.3.1.3. France
13.3.1.4. Italy
13.3.1.5. Spain
13.3.1.6. Russia
13.3.1.7. Nordic
13.3.1.8. Poland
13.3.1.9. Rest of Europe
13.3.2. By Drug Type
13.3.3. By Indication
13.3.4. By Distribution Channel
13.4. Market Attractiveness Analysis
14. South Asia Market Analysis 2018-2022 and Forecast 2023-2033
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022
14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2023-2033
14.3.1. By Country
14.3.1.1. India
14.3.1.2. Thailand
14.3.1.3. Indonesia
14.3.1.4. Malaysia
14.3.1.5. Rest of South Asia
14.3.2. By Drug Type
14.3.3. By Indication
14.3.4. By Distribution Channel
14.4. Market Attractiveness Analysis
15. East Asia Market Analysis 2018-2022 and Forecast 2023-2033
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022
15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2023-2033
15.3.1. By Country
15.3.1.1. China
15.3.1.2. Japan
15.3.1.3. South Korea
15.3.2. By Drug Type
15.3.3. By Indication
15.3.4. By Distribution Channel
15.4. Market Attractiveness Analysis
16. Oceania Market Analysis 2018-2022 and Forecast 2023-2033
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022
16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2023-2033
16.3.1. By Country
16.3.1.1. Australia
16.3.1.2. New Zealand
16.3.2. By Drug Type
16.3.3. By Indication
16.3.4. By Distribution Channel
16.4. Market Attractiveness Analysis
17. Middle East and Africa Market Analysis 2018-2022 and Forecast 2023-2033
17.1. Introduction
17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022
17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2023-2033
17.3.1. By Country
17.3.1.1. GCC Countries
17.3.1.2. Iran
17.3.1.3. Israel
17.3.1.4. Turkey
17.3.1.5. Rest of Middle East and Africa
17.3.2. By Drug Type
17.3.3. By Indication
17.3.4. By Distribution Channel
17.4. Market Attractiveness Analysis
18. Emerging Countries Market Analysis 2018-2022 and Forecast 2023-2033
18.1. Introduction
18.1.1. Market Value Proportion Analysis, By Key Countries
18.1.2. Global Vs. Country Growth Comparison
18.2. China Market Analysis
18.2.1. Introduction
18.2.2. Market Value Proportion Analysis by Market Taxonomy
18.2.3. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy
18.2.3.1. By Drug Type
18.2.3.2. By Distribution Channel
18.2.3.3. By Indication
18.2.4. China Market – Competition Landscape
18.2.5. China – Trade Analysis
18.3. India Market Analysis
18.3.1. Introduction
18.3.2. Market Value Proportion Analysis by Market Taxonomy
18.3.3. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy
18.3.3.1. By Drug Type
18.3.3.2. By Distribution Channel
18.3.3.3. By Indication
18.3.4. India Market – Competition Landscape
18.4. Brazil Market Analysis
18.4.1. Introduction
18.4.2. Market Value Proportion Analysis by Market Taxonomy
18.4.3. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy
18.4.3.1. By Drug Type
18.4.3.2. By Distribution Channel
18.4.3.3. By Indication
18.4.4. Mexico Market – Competition Landscape
19. Competition Analysis
19.1. Competition Dashboard
19.2. Competition Deep Dive
19.2.1. Axovant Sciences Ltd.
19.2.1.1. Overview
19.2.1.2. Global Manufacturing Sites
19.2.1.3. Drug Sales Footprint
19.2.1.4. Key Financials
19.2.1.5. Analyst Commentary
19.2.2. BioArctic AB
19.2.2.1. Overview
19.2.2.2. Global Manufacturing Sites
19.2.2.3. Drug Sales Footprint
19.2.2.4. Key Financials
19.2.2.5. Analyst Commentary
19.2.3. Eisai Co., Ltd.
19.2.3.1. Overview
19.2.3.2. Global Manufacturing Sites
19.2.3.3. Drug Sales Footprint
19.2.3.4. Key Financials
19.2.3.5. Analyst Commentary
19.2.4. Sumitomo Dainippon Pharma Co., Ltd.
19.2.4.1. Overview
19.2.4.2. Global Manufacturing Sites
19.2.4.3. Drug Sales Footprint
19.2.4.4. Key Financials
19.2.4.5. Analyst Commentary
19.2.5. Jazz Pharmaceuticals, Inc.
19.2.5.1. Overview
19.2.5.2. Global Manufacturing Sites
19.2.5.3. Drug Sales Footprint
19.2.5.4. Key Financials
19.2.5.5. Analyst Commentary
19.2.6. Immungenetics AG
19.2.6.1. Overview
19.2.6.2. Global Manufacturing Sites
19.2.6.3. Drug Sales Footprint
19.2.6.4. Key Financials
19.2.6.5. Analyst Commentary
19.2.7. Noven Pharmaceuticals, Inc.
19.2.7.1. Overview
19.2.7.2. Global Manufacturing Sites
19.2.7.3. Drug Sales Footprint
19.2.7.4. Key Financials
19.2.7.5. Analyst Commentary
19.2.8. Eli Lilly and Company
19.2.8.1. Overview
19.2.8.2. Global Manufacturing Sites
19.2.8.3. Drug Sales Footprint
19.2.8.4. Key Financials
19.2.8.5. Analyst Commentary
19.2.9. Novartis AG
19.2.9.1. Overview
19.2.9.2. Global Manufacturing Sites
19.2.9.3. Drug Sales Footprint
19.2.9.4. Key Financials
19.2.9.5. Analyst Commentary
19.2.10. Pfizer Inc.
19.2.10.1. Overview
19.2.10.2. Global Manufacturing Sites
19.2.10.3. Drug Sales Footprint
19.2.10.4. Key Financials
19.2.10.5. Analyst Commentary
19.2.11. Bayer AG
19.2.11.1. Overview
19.2.11.2. Global Manufacturing Sites
19.2.11.3. Drug Sales Footprint
19.2.11.4. Key Financials
19.2.11.5. Analyst Commentary
19.2.12. Mylan NV
19.2.12.1. Overview
19.2.12.2. Global Manufacturing Sites
19.2.12.3. Drug Sales Footprint
19.2.12.4. Key Financials
19.2.12.5. Analyst Commentary
19.2.13. Sanofi AG
19.2.13.1. Overview
19.2.13.2. Global Manufacturing Sites
19.2.13.3. Drug Sales Footprint
19.2.13.4. Key Financials
19.2.13.5. Analyst Commentary
19.2.14. Teva Pharmaceutical Industries Limited
19.2.14.1. Overview
19.2.14.2. Global Manufacturing Sites
19.2.14.3. Drug Sales Footprint
19.2.14.4. Key Financials
19.2.14.5. Analyst Commentary
19.2.15. GlaxoSmithKline plc
19.2.15.1. Overview
19.2.15.2. Global Manufacturing Sites
19.2.15.3. Drug Sales Footprint
19.2.15.4. Key Financials
19.2.15.5. Analyst Commentary
19.2.16. Takeda Pharmaceutical Company Limited
19.2.16.1. Overview
19.2.16.2. Global Manufacturing Sites
19.2.16.3. Drug Sales Footprint
19.2.16.4. Key Financials
19.2.16.5. Analyst Commentary
19.2.17. Allergan plc
19.2.17.1. Overview
19.2.17.2. Global Manufacturing Sites
19.2.17.3. Drug Sales Footprint
19.2.17.4. Key Financials
19.2.17.5. Analyst Commentary
19.2.18. Janssen Pharmaceuticals, Inc.
19.2.18.1. Overview
19.2.18.2. Global Manufacturing Sites
19.2.18.3. Drug Sales Footprint
19.2.18.4. Key Financials
19.2.18.5. Analyst Commentary
19.2.19. Bausch Health Companies Inc.
19.2.19.1. Overview
19.2.19.2. Global Manufacturing Sites
19.2.19.3. Drug Sales Footprint
19.2.19.4. Key Financials
19.2.19.5. Analyst Commentary
19.2.20. Mallinckrodt Pharmaceuticals
19.2.20.1. Overview
19.2.20.2. Global Manufacturing Sites
19.2.20.3. Drug Sales Footprint
19.2.20.4. Key Financials
19.2.20.5. Analyst Commentary
20. Assumptions and Acronyms Used
21. Research Methodology
Table 01 : Global Market Pipeline Assessment – Clinical TrialsTable 02: Global Market size (US$ Mn) Analysis 2018-2022 and forecast 2023-2033, By Drug Type
Table 03: Global Market size (US$ Mn) Analysis 2018-2022 and forecast 2023-2033, By Indication
Table 04: Global Market size (US$ Mn) Analysis 2018-2022 and forecast 2023-2033, By Distribution Channel
Table 05: Global Market size (US$ Mn) Analysis 2018-2022 and forecast 2023-2033, By Region
Table 06: North America Market size (US$ Mn) Analysis 2018-2022 and forecast 2023-2033, By Country
Table 07: North America Market size (US$ Mn) Analysis 2018-2022 and forecast 2023-2033, By Indication
Table 08: North America Market size (US$ Mn) Analysis 2018-2022 and forecast 2023-2033, By Drug Type
Table 09: North America Market size (US$ Mn) Analysis 2018-2022 and forecast 2023-2033, By Distribution Channel
Table 10: Latin America Market size (US$ Mn) Analysis 2018-2022 and forecast 2023-2033, By Country
Table 11: Latin America Market size (US$ Mn) Analysis 2018-2022 and forecast 2023-2033, By Indication
Table 12: Latin America Market size (US$ Mn) Analysis 2018-2022 and forecast 2023-2033, By Drug Type
Table 13: Latin America Market size (US$ Mn) Analysis 2018-2022 and forecast 2023-2033, By Distribution Channel
Table 14: Europe Market size (US$ Mn) Analysis 2018-2022 and forecast 2023-2033, By Country
Table 15: Europe Market size (US$ Mn) Analysis 2018-2022 and forecast 2023-2033, By Indication
Table 16: Europe Market size (US$ Mn) Analysis 2018-2022 and forecast 2023-2033, By Drug Type
Table 17: Europe Market size (US$ Mn) Analysis 2018-2022 and forecast 2023-2033, By Distribution Channel
Table 18: South Asia Market size (US$ Mn) Analysis 2018-2022 and forecast 2023-2033, By Country
Table 19: South Asia Market size (US$ Mn) Analysis 2018-2022 and forecast 2023-2033, By Indication
Table 20: South Asia Market size (US$ Mn) Analysis 2018-2022 and forecast 2023-2033, By Drug Type
Table 21: South Asia Market size (US$ Mn) Analysis 2018-2022 and forecast 2023-2033, By Distribution Channel
Table 22: East Asia Market size (US$ Mn) Analysis 2018-2022 and forecast 2023-2033, By Country
Table 23: East Asia Market size (US$ Mn) Analysis 2018-2022 and forecast 2023-2033, By Indication
Table 24: East Asia Market size (US$ Mn) Analysis 2018-2022 and forecast 2023-2033, By Drug Type
Table 25: East Asia Market size (US$ Mn) Analysis 2018-2022 and forecast 2023-2033, By Distribution Channel
Table 26: Oceania Market size (US$ Mn) Analysis 2018-2022 and forecast 2023-2033, By Country
Table 27: Oceania Market size (US$ Mn) Analysis 2018-2022 and forecast 2023-2033, By Indication
Table 28: Oceania Market size (US$ Mn) Analysis 2018-2022 and forecast 2023-2033, By Drug Type
Table 29: Oceania Market size (US$ Mn) Analysis 2018-2022 and forecast 2023-2033, By Distribution Channel
Table 30: MEA Market size (US$ Mn) Analysis 2018-2022 and forecast 2023-2033, By Country
Table 31: MEA Market size (US$ Mn) Analysis 2018-2022 and forecast 2023-2033, By Indication
Table 32: MEA Market size (US$ Mn) Analysis 2018-2022 and forecast 2023-2033, By Drug Type
Table 33: MEA Market size (US$ Mn) Analysis 2018-2022 and forecast 2023-2033, By Distribution Channel
Table 34: China Market size (US$ Mn) Analysis 2018-2022 and forecast 2023-2033, By Drug Type
Table 35: China Market size (US$ Mn) Analysis 2018-2022 and forecast 2023-2033, By Indication
Table 36: China Market size (US$ Mn) Analysis 2018-2022 and forecast 2023-2033, By Distribution Channel
Table 37: India Market size (US$ Mn) Analysis 2018-2022 and forecast 2023-2033, By Drug Type
Table 38: India Market size (US$ Mn) Analysis 2018-2022 and forecast 2023-2033, By Indication
Table 39: India Market size (US$ Mn) Analysis 2018-2022 and forecast 2023-2033, By Distribution Channel
Table 40: Brazil Market size (US$ Mn) Analysis 2018-2022 and forecast 2023-2033, By Drug Type
Table 41: Brazil Market size (US$ Mn) Analysis 2018-2022 and forecast 2023-2033, By Indication
Table 42: Brazil Market size (US$ Mn) Analysis 2018-2022 and forecast 2023-2033, By Distribution Channel
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
